FDA with the association of manufacturers will the working on including this new information in the labeling for these products and that way they will appear on the market,” says the US drug safety regulator.
On Friday, the US drug safety regulator informed that the anti-epileptic drugs used to cure migraine headaches, epilepsy and other conditions carry a risk of suicidal behavior and thoughts.
Related News:
- FDA Drug Safety Communication: Children born to mothers who took Valproate products while pregnant may have impaired cognitive development
- FDA Drug Safety Communication: Ongoing safety review of oral osteoporosis drugs (bisphosphonates) and potential increased risk of esophageal cancer
- Diabetes Drug Byetta could bring Pancreas Risk?
- Questions and Answers: 5-alpha reductase inhibitors (5-ARIs) may increase the risk of a more serious form of prostate cancer
- Oral Osteoporosis Drugs (bisphosphonates): Drug Safety Communication – Potential Increased Risk of Esophageal Cancer